Patients should be informed when AI systems are used in clinical trials

Nat Med. 2023 Aug;29(8):1890-1891. doi: 10.1038/s41591-023-02367-8.

Subha Perni^{1

2

3}, Lisa Soleymani Lehmann^{2

4}, Danielle S Bitterman^{5

6}

¹ Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
² Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
³ MD Anderson Cancer Center, Houston, TX, USA.
⁴ Harvard T.H. Chan School of Public Health, Harvard Medical School, Boston, MA, USA.
⁵ Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA. Danielle_Bitterman@dfci.harvard.edu.
⁶ Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Danielle_Bitterman@dfci.harvard.edu.

No abstract available

Publication types